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Ovarian cancer is the second leading cause of death among women in the gynaecological 
category of cancers. The current post surgery treatment which involves the use of platinum-
based therapy with its attendant adverse drug-resistance often results in the return of the 
cancer. This study explored the role of phytochemicals as the major source of new drugs by 
the evaluation of the anti-ovarian cancer activities of three selected Nigerian medicinal plants 
(Acalypha wilkesiana, Margaritaria discoidea and Rutidea parviflora). Using a bioassay-
guided approach, an investigation of the cell growth inhibition of the extracts/fractions of 
these plants on four human ovarian cancer cell lines, A2780, OVCAR 4, OVCAR 8, and CIS-
A2780 showed that these plant extracts had promising anti-ovarian cancer activities. The 
bioactive compounds of the plants were isolated by HPLC, identified by mass 
spectrometry/NMR spectroscopy and investigated for cytotoxicity. Gallic acid (IC50 range of 
6.2±0.3 – 26.9±4.1 µM) was the active compound in A. wilkesiana. The significantly 
bioactive compounds of M. discoidea were securinine (IC50 range of 2.7±0.7 – 8.7±0.1 µM) 
[1], betulinic acid (IC50 of 16.0±1.9 µM), and gallic acid. While palmatine (IC50 range of 
5.5±0.9 – 7.9±0.5 µM) was the major active compound in R. parviflora. Palmatine, and 
securinine showed induction of apoptosis via increased caspase 3/7 activity. Palmatine 
demonstrated PAPR cleavage by western blot analysis. These studies have provided 
scientific evidences for the potential treatment of ovarian cancer with these traditional 
medicinal plants and hit compounds for future optimization towards clinical trials. 
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